tiprankstipranks
Bolt Biotherapeutics (BOLT)
NASDAQ:BOLT
US Market
BOLT
Bolt Biotherapeutics
RESEARCH TOOLSreports

Bolt Biotherapeutics (BOLT) Financial Statements

Compare
242 Followers

Bolt Biotherapeutics Financial Overview

Bolt Biotherapeutics's market cap is currently $8.65M. The company's EPS TTM is $-3.84; its P/E ratio is -0.31; Bolt Biotherapeutics is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is $-2.85. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 7.70M$ 7.69M$ 7.88M$ 5.73M$ 1.26M
Gross Profit$ 6.20M$ 7.69M$ -53.67M$ -67.39M$ -74.39M
Operating Income$ -34.63M$ -73.05M$ -76.20M$ -90.32M$ -92.79M
EBITDA$ -33.14M$ -66.45M$ -74.34M$ -88.66M$ -91.59M
Net Income$ -33.38M$ -63.12M$ -69.20M$ -88.10M$ -98.59M
Balance Sheet
Cash & Short-Term Investments$ 27.50M$ 47.32M$ 102.19M$ 168.89M$ 186.22M
Total Assets$ 56.75M$ 99.63M$ 159.78M$ 227.81M$ 307.72M
Total Debt$ 22.96M$ 25.21M$ 20.22M$ 22.61M$ 24.36M
Net Debt$ 11.26M$ 18.00M$ 9.41M$ 13.37M$ -3.03M
Total Liabilities$ 30.24M$ 42.43M$ 47.04M$ 56.30M$ 57.60M
Stockholders' Equity$ 26.50M$ 57.20M$ 112.74M$ 171.51M$ 250.12M
Cash Flow
Free Cash Flow$ -39.92M$ -61.33M$ -69.73M$ -78.46M$ -59.40M
Operating Cash Flow$ -39.85M$ -61.29M$ -69.53M$ -76.50M$ -57.07M
Investing Cash Flow$ 44.30M$ 57.58M$ 71.04M$ 57.86M$ -232.20M
Financing Cash Flow$ 19.00K$ 108.00K$ 253.00K$ 503.00K$ 311.11M
Currency in USD

Bolt Biotherapeutics Earnings and Revenue History

Income Statement >

Bolt Biotherapeutics Debt to Assets

Balance Sheet >

Bolt Biotherapeutics Cash Flow

Cash Flow >

Bolt Biotherapeutics Forecast EPS vs Actual EPS

Earnings >